Detailed Information
Cited 0 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
A phase 1a/b study of BR101801, a PI3K gamma delta and DNA PK triple inhibitor, in adult patients with advanced hematologic malignancies
- Authors
- Kim, BS[Kim, Bong-Seog]; Kim, SJ[Kim, Seok Jin]; Kim, TM[Kim, Tae Min]; Yoon, DH[Yoon, Dok Hyun]; Kim, JS[Kim, Jin Seok]; Lee, E[Lee, Eunyoung]; Lee, WS[Lee, Won-Sik]; Lee, JO[Lee, Jeong-Ok]; Yang, DH[Yang, Deok-Hwan]
- Issue Date
- 1-Jun-2023
- Publisher
- LIPPINCOTT WILLIAMS & WILKINS
- Citation
- JOURNAL OF CLINICAL ONCOLOGY, v.41, no.16
- Indexed
- SCIE
SCOPUS
- Journal Title
- JOURNAL OF CLINICAL ONCOLOGY
- Volume
- 41
- Number
- 16
- ISSN
- 0732-183X
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Medicine > Department of Medicine > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.